MANE News & Events

The deal size was increased to 3.84M shares from 3.35M and priced below last closing price of $106.55. Jefferies, Leerink, Citi and Cantor Fitzgerald are acting as joint book running managers for the offering.

Veradermics announced that it has launched a proposed public offering of 3.35M shares of common stock pursuant to a registration statement filed on Form S-1 with the SEC. All of the shares and pre-funded warrants are being offered by Veradermics. Jefferies, Leerink Partners, Citigroup, and Cantor are acting as joint bookrunning managers for the proposed offering. LifeSci is acting as passive bookrunner for the proposed offering. Needham & Company is acting as lead manager for the proposed offering.

Veradermics files to sell 3.35M shares of common stock

The major averages had a mixed close amid stalled peace negotiations between the U.S. and Iran as well as new escalation in the Strait of Hormuz. Investors are also balancing continued strength in corporate earnings and AI-driven optimism with rising geopolitical tension and macro uncertainty.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Verizonprovided areport for Q1Domino's Pizzareportedand announced an additional $1B share repurchase programShellARC Resourcesfor C$32.80 per shareSun PharmaOrganonfor $14 per share in an all-cash transactionChina has blocked Meta's2. WALL STREET CALLS:Snapto Buy at Rothschild & Co RedburnRothschildPinterestto Neutral from BuyMizuhoAdobeon intensifying competition from AIMizuhoCrowdStrike, citing "numerous exciting growth avenues"Campbell'sto Market Perform at Bernstein3. AROUND THE WEB:Rogers Communicationsis offering voluntary buyouts to half of its staff, Globe and Mail reportsGoogleemployees are urging CEO Sundar Pichai to block military AI use, FT reportsSamsungplans to withdraw from China's home appliance and television market this year, Nikkei Asia reportsBig tech companies are preparing to spend hundreds of billions of dollars on AI infrastructure, with most of their plans dependent on ASML, WSJ saysBayeris hoping the U.S. Supreme Court can reduce or simplify the lawsuits over its Roundup weedkiller and potentially corral litigation that has cost the company over $10B, Bloomberg says4. MOVERS:Veradermicsgained after announcing its Phase 2/3 trial of VDPHL01RE/MAX Holdingsincreased after announcing it will befor $13.80 per shareFlowserve (FLS) rose afterthat Starboard has built a stake in the company and is pushing for changesCompass Therapeuticswas lower afterfrom its COMPANION-002 studyPoet Technologiesfell afterof Celestial AI purchase orders5. EARNINGS/GUIDANCE:Lakeland Financial, with CEO David Findlay commenting, "We started 2026 with robust, record net income for the second consecutive quarter"HBT Financial, with EPS and revenue beating consensusRepay Holdingsreportedand reaffirmed its guidance for FY26WWreaffirmed itsand FY26 financial guidanceGold RoyaltyreportedINDEXES:The Dow fell 62.92, or 0.13%, to 49,167.79, the Nasdaq gained 50.50, or 0.20%, to 24,887.10, and the S&P 500 advanced 8.83, or 0.12%, to 7,173.91.